|
 |
 |

RESEARCH
Science
Veterinary
Medicine
Illinois study seeking biomarkers
of canine diabetes, other disease
Jim Barlow,
Life Sciences Editor
(217) 333-5802; jebarlow@uiuc.edu
10/7/03
CHAMPAIGN, Ill. —
While the
genetic blueprint for Shadow the poodle was being completed in Maryland,
researchers at the University of Illinois at Urbana-Champaign have been
engaged in a long-term study that they hope will add functional gene
information to the dog genome as well as benefit both canine and human
health.
The still-in-progress Illinois study, in which researchers are measuring
the effects of diet on gene expression in both weanling and geriatric
dogs, is described in a paper in the October issue of the Journal of
Nutrition. The scientists use their study as an example of how the use
of emerging molecular tools, in general, will unlock the functional
aspects of the genes being mapped in a variety of genomes.
"Genome sequencing allows us to understand health across animals,"
said Lawrence B. Schook, a professor of animal
sciences and veterinary pathobiology
at Illinois. "Dogs, like humans, get diseases associated with lifestyles.
Thus not exercising and over-eating can result in obesity and diabetes.
Information about human diseases can be used to treat dogs, and understanding
dog diseases can be used to treat humans."
The dog-human bond goes deeper than mutual admiration. In a paper published
last month in Science, researchers at the Institute for Genomic Research
in Maryland scientists reported that their genome map of Shadow reveals
18,473 genes that correspond to the 24,567 annotated human genes. They
also noted that the dog’s genome had more genetic similarities
with humans than does the mouse – the most-often used mammal for
human health studies.
Schook and colleagues say in their paper that the cat-genome map available
to date is even more similar to humans genetically than the dog. To
date, Schook said, 263 feline and 451 canine genetic diseases have been
identified.
Causes for diseases associated with a single gene can be uncovered with
current biological techniques, Schook said, but finding the source of
diseases associated with multiple genes "is a much more daunting
task."
The emergence of mammal genomes provides fundamental gene-placement
information, but now researchers are able to pursue functional genomics
to unlock the mysteries of RNA and protein expression. Such research,
Schook and colleagues write, will enhance our knowledge of metabolism
and improve companion animal nutrition and health.
The dog, they say, "may be a very useful model, as many of the
most common diseases of purebred dogs are also major health concerns
in humans." They cite arthritis, cancer, deafness, heart disease,
blindness, epilepsy and chronic metabolic diseases.
In the Illinois study, a diet of mostly high-quality animal-based ingredients
is being compared with a mainly plant-based diet.
Researchers are analyzing ribonucleic acid (RNA) samples to generate
gene expression profiles of some 384 genes associated with metabolism
and immune function. They also are monitoring digestion, fetal microbes
and concentrations of fermented end products to measure the effects
of dietary changes.
Illinois scientists hope the project will identify biomarkers that can
predict diabetes, a disease that is appearing among the 40 percent of
aging overweight dogs and cats in the United States, and other medical
issues.
The general study of metabolic profiles of cells, tissues and organisms
is designed to identify molecular markers that reflect nutritional and/or
health status. Eventually, Schook said, such studies could result in
animal feed that includes functional ingredients to help prevent and
treat diseases in general or to target breed-specific genetic problems.
Schook’s collaborators are George Fahey, professor of animal
sciences, and Kelly Swanson, a postdoctoral fellow in animal
sciences. Pyxis Genomics of Chicago supports their research. Schook
is a member of the board of directors of the privately held company
that focuses on genetic research on natural disease resistance in food
animals, preventive medicine for dogs and cats, food safety and security,
and human therapeutics.
|
 |
 |
|